Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. - PubMed - NCBI

N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17. Comparative Study; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't